Genomics

Dataset Information

40

MRNA- and RISC-sequencing of mouse hearts overexpressing miR-378a


ABSTRACT: Rationale: MicroRNAs play key roles in hypertrophic stress responses. miR-378(-3p) is a highly abundant, cardiomyocyte-enriched microRNA whose downregulation in pressure-overload has been suggested as detrimental to the heart. Previous studies have utilized systemic anti-miR or microRNA-encoding virus administration, and thus questions regarding the cardiomyocyte-autonomous roles of miR-378 remain. Objective: To examine whether persistent overexpression of miR-378 in cardiomyocytes alters the phenotype of the unstressed heart, whether its overexpression is beneficial or deleterious in the setting of pressure-overload, and to comprehensively identify its cardiomyocyte-specific effects on mRNA regulation. Methods and Results: Cardiac function was compared in young (10-12 week-old) mice overexpressing miR-378 in the heart under the control of the Myh6 promoter (alphaMHC-miR-378 mice), in older (40 week-old) mice and their age-matched wild-type controls. Older alphaMHC-miR-378 mice exhibited decreased fractional shortening and modest chamber dilation with an increase in cardiomyocyte length. When subjected to pressure-overload, cardiomyocyte length was increased in young alphaMHC-miR-378 mice, but fractional shortening declined precipitously over two weeks. Transcriptome profiling of wild-type and alphaMHC-miR-378 hearts in unstressed and pressure-overload conditions revealed dysregulation of several upstream metabolic and mitochondrial genes in alphaMHC-miR-378 hearts, compromising the reprogramming that occurs during early adaptation to pressure overload. Ago2 immunoprecipitation with mRNA sequencing revealed novel miR-378 cardiac mRNA targets including Akt1 and Epac2 and demonstrated the contextual nature of previously described miR-378 targeting events. Conclusions: Long-term upregulation of miR-378 levels in the heart is not innocuous and exacerbates contractile dysfunction in pressure-overload hypertrophy through numerous signaling mechanisms. Overall design: Cardiac polyadenylated RNA (mRNA) or RISC-seq (total RNA-seq of Ago2 immunoprecipitate) profiles were generated from nontransgenic and transgenic mouse hearts of FVB/N background, on Illumina HiSeq 2000 instruments. Male mice 8-12 weeks of age were used in these studies, and subjected to sham surgery or 2 weeks of pressure-overload via transverse aortic constriction (TAC). 3 nontransgenic sham, 3 transgenic sham, 7 nontransgenic TAC, 7 transgenic TAC, each with mRNA-seq and RISC-seq data.

INSTRUMENT(S): Illumina HiSeq 2000 (Mus musculus)

SUBMITTER: Scot J Matkovich  

PROVIDER: GSE61734 | GEO | 2015-09-30

SECONDARY ACCESSION(S): PRJNA262042

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
GSE61734_RAW.tar Raw
GSE61734_all_RISC_samples_miR378_study_HTSeq_count.txt.gz Txt
GSE61734_all_mRNA_samples_miR378_study_HTSeq_count.txt.gz Txt
GSE61734_mm10_UCSC_genes.gtf.gz Other
filelist.txt Txt
Items per page:
1 - 5 of 5
altmetric image

Publications

Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs.

Matkovich Scot J SJ   Dorn Gerald W GW   Grossenheider Tiffani C TC   Hecker Peter A PA  

Circulation. Cardiovascular genetics 20151109 6


<h4>Background</h4>MicroRNAs are key players in cardiac stress responses, but the mRNAs, whose abundance and translational potential are primarily affected by changes in cardiac microRNAs, are not well defined. Stimulus-induced, large-scale alterations in the cardiac transcriptome, together with consideration of the law of mass action, further suggest that the mRNAs most substantively targeted by individual microRNAs will vary between unstressed and stressed conditions. To test the hypothesis th  ...[more]

Similar Datasets

2016-01-11 | E-GEOD-65141 | ArrayExpress
2015-01-01 | S-EPMC4303543 | BioStudies
2015-01-01 | S-EPMC4681654 | BioStudies
2016-01-01 | S-EPMC4767297 | BioStudies
2018-01-01 | S-EPMC6005806 | BioStudies
1000-01-01 | S-EPMC6064988 | BioStudies
2020-01-01 | S-EPMC7492881 | BioStudies
2014-01-01 | S-EPMC4037364 | BioStudies
2014-01-01 | S-EPMC4300109 | BioStudies
2019-01-01 | S-EPMC6777911 | BioStudies